Recently, Next-Generation Sequencing (NGS) has opened up a new perspective to understand human aging and disease along with the rapid development of information processing technology.
In particular, single-cell multi-omics analysis will be the cornerstone of an innovative diagnostic platform that diagnoses illnesses for which there is no known treatment and accurately identifies the patient’s condition to derive the most effective treatment method.
Einocle aims to grow into a biotechnology company that plays a positive role in the fields of genetic analysis, bioinformatics, and next-generation precision medicine.
Based on rich experience and advanced technology, we will gather talented individuals and grow into a cutting-edge biotechnology company that positively affects many more people.